NCT06680726Recruiting
Research Collaboration for a Precision Oncology Program (POP)
Summary
The Precision Oncology Program (POP) research collaboration aims to help generate information about the individual tumour biology for patients with advanced malignancies, using innovative biotechnologies and patient profile comparison ("matching") against specific databases (Real-world data, RWD) and to inform about potential benefit, or lack of benefit, from a given treatment.
Inclusion criteria
• Signed informed consent • In the case of deceased persons: signed general consent • All patients with the diagnosis of a solid tumour including adenocarcinoma, squamous cell carcinoma, neuroendocrine carcinoma, sarcoma, etc • ECOG-performance status 0-2, if applicable • Willing and able to understand all project related procedures, including transfer of coded (i.e. pseudonymised) or anonymized clinical data to external partners (e.g. Roche), if applicable
Exclusion criteria
• Patients with the diagnosis of blood cancer.
Contacts
The trial team's contact details are shown on request.
See the official trial record- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Countries
- Switzerland
- Sponsor
- Andreas Wicki(Other)
- Protocol no.
- POP
- Conditions
- Cancer
- Interventions
- Other
Treatments studied
- Matching with RWD
- Imaging Mass Cytometry
Collaborators
Hoffmann-La Roche, University of Zurich, University Hospital, Zürich
Locations · 1
- Zurich, SwitzerlandUniversity Hospital Zürich (Universitätsspital Zürich)Recruiting at this site
In total, worldwide, the only site listed in the registry is recruiting.
Site status per the ClinicalTrials.gov registry (last update posted: November 8, 2024).
This status may have changed and says nothing about your eligibility: before taking any step, check with your oncologist or the site.
Other identifiers
- 2022-02289 · other identifier
See also
Other versions
These results are indicative and do not replace medical advice — discuss them with your doctor.